克拉米迪亚肺炎-免疫球蛋白E抗体响应从患有喘的儿童的血清中
Tamar A Smith-Norowitz1, Anastasiya Shulman1, Haram Abdelmajid1
1State University of New York Downstate Health Sciences University, Brooklyn, NY 11203, USA.
Pathogens and disease
|July 5, 2023
概括
冠状病毒肺炎特异性免疫球蛋白E (IgE) 抗体可能表明喘儿童的持续性免疫激活. 这种与干扰素-相关的免疫反应可能会导致持续的喘症状.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 冠状病毒肺炎是一种导致呼吸道感染的细菌.
- 持续的C. pneumoniae感染与喘的发展有关.
- 特定免疫球蛋白E (IgE) 作为持续免疫反应标记物的作用尚不清楚.
研究的目的:
- 调查C. pneumoniae特异性IgE抗体与干扰素- (IFN-γ) 生产之间的关联.
- 确定C. pneumoniae特异性IgE是否是喘儿童持续免疫激活的标志物.
主要方法:
- 来自63名儿童的外周血液单核细胞 (PBMC) (45名患有喘,18名没有) 用C. pneumoniae培养.
- 用ELISA测量细胞培养超级生物中的干扰素马 (IFN-γ) 水平.
- 通过免疫阻塞检测检测出血清C. pneumoniae特异性的IgE抗体.
主要成果:
- 在喘儿童的27%中发现了针对C. pneumoniae的IgE抗体,而非喘儿童的这一比例为11% (不具有统计学意义).
- 在患有C. pneumoniae特异性IgE (60%) 的喘儿童中,IFN-γ反应比没有 (20%) 的儿童更常见 (P=0.1432).
- 针对C. pneumoniae刺激的IFN-γ产生在具有特定IgE抗体的喘儿童中更为频繁.
结论:
- 患有喘的儿童中存在C. pneumoniae特异性的IgE抗体可能表明持续的免疫激活.
- 这种以IFN-γ产生为特征的免疫反应可能与持续的喘症状有关,可能反映了持续的感染.
相关概念视频
Bacterial Phylum Chlamydiae
38
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
38
Pneumonia III: Complications and Assessment
275
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
275
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
354
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
354
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K


